| Regulatory T cells: regulation of identity and function P Grover, PN Goel, MI Greene Frontiers in immunology 12, 750542, 2021 | 86 | 2021 |
| Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway Y Jia, KN Kodumudi, G Ramamoorthi, A Basu, C Snyder, D Wiener, ... Molecular Therapy 29 (4), 1-16, 2021 | 24 | 2021 |
| A novel helper phage enabling construction of genome-scale ORF-enriched phage display libraries A Gupta, N Shrivastava, P Grover, A Singh, K Mathur, V Verma, C Kaur, ... PloS one 8 (9), e75212, 2013 | 24 | 2013 |
| Rapid restriction enzyme-free cloning of PCR products: a high-throughput method applicable for library construction VK Chaudhary, N Shrivastava, V Verma, S Das, C Kaur, P Grover, ... PLoS One 9 (10), e111538, 2014 | 14 | 2014 |
| Biotin-tagged proteins: Reagents for efficient ELISA-based serodiagnosis and phage display-based affinity selection V Verma, C Kaur, P Grover, A Gupta, VK Chaudhary PLoS One 13 (1), e0191315, 2018 | 12 | 2018 |
| FOXP3 and Tip60 structural interactions relevant to IPEX development lead to potential therapeutics to increase FOXP3 dependent Suppressor T cell functions P Grover, PN Goel, CA Piccirillo, MI Greene Frontiers in Pediatrics 9, 1-11, 2021 | 10 | 2021 |
| PRMT5 and Tip60 modify FOXP3 function in tumor immunity PN Goel, P Grover, MI Greene Critical Reviews™ in Immunology 40 (4), 2020 | 9 | 2020 |
| Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma G Ramamoorthi, K Kodumudi, C Snyder, P Grover, H Zhang, MI Greene, ... Journal for Immunotherapy of Cancer 10 (6), 2022 | 6 | 2022 |
| Challenges in detection of serum oncoprotein: relevance to breast cancer diagnostics J Lengfeld, H Zhang, S Stoesz, R Murali, F Pass, MI Greene, PN Goel, ... Breast Cancer: Targets and Therapy, 575-593, 2021 | 6 | 2021 |
| Thrombosis after SARS-CoV2 infection or COVID-19 vaccination: will a nonpathologic anti-PF4 antibody be a solution?—A narrative review E Rao, P Grover, H Zhang Journal of bio-X research 5 (3), 97-103, 2022 | 2 | 2022 |
| Signaling of the erbb receptor family in carcinogenesis and the development of targeted therapies Z Cai, P Grover, Z Zhu, MI Greene, H Zhang Predictive Biomarkers in Oncology: Applications in Precision Medicine, 231-242, 2019 | 2 | 2019 |
| Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancer PN Goel, H Zhang, R Murali, C Zheng, MQ Ji, A Patterson, P Grover, ... Biochemical and Biophysical Research Communications 651, 39-46, 2023 | 1 | 2023 |
| F77 antigen is a promising target for adoptive T cell therapy of prostate cancer P Grover, S Nunez-Cruz, J Leferovich, T Wentz, A Bagchi, MC Milone, ... Biochemical and Biophysical Research Communications 680, 51-60, 2023 | | 2023 |
| A process for immobilizing polypeptides VK Chaudhary, A Gupta, V Verma, K Charanpreet, P Grover US Patent App. 16/762,770, 2020 | | 2020 |
| Immune Cytokines for Cancer Therapy P Grover, JJ Cui, Y Wang, H Zhang Cancer Studies and Therapeutics 4 (2), 1-8, 2019 | | 2019 |
